Diagnos Inc (DGNOF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -2,106 | -1,273 | -524 | -2,313 | -1,698 |
| Depreciation Amortization | 69 | 47 | 21 | 92 | 68 |
| Accounts receivable | N/A | N/A | N/A | 72 | N/A |
| Other Working Capital | -114 | 9 | -188 | 114 | 64 |
| Other Operating Activity | 439 | 261 | 132 | 444 | 370 |
| Operating Cash Flow | $-1,712 | $-956 | $-559 | $-1,592 | $-1,196 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -1,964 | -1,466 | -365 | 0 | -588 |
| PPE Investments | -8 | -5 | N/A | -8 | -7 |
| Sale Of Investment | N/A | N/A | N/A | N/A | 441 |
| Other Investing Activity | 3 | 0 | 0 | -2 | 0 |
| Investing Cash Flow | $-1,970 | $-1,471 | $-365 | $-10 | $-154 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 626 | 620 |
| Common Stock Issued | 3,822 | 2,794 | 949 | 1,213 | 797 |
| Other Financing Activity | -246 | -167 | -84 | -293 | -208 |
| Financing Cash Flow | $3,575 | $2,627 | $865 | $1,545 | $1,209 |
| Beginning Cash Position | 156 | 161 | 160 | 220 | 218 |
| End Cash Position | 50 | 360 | 101 | 162 | 77 |
| Net Cash Flow | $-106 | $200 | $-59 | $-58 | $-141 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,712 | -956 | -559 | -1,592 | -1,196 |
| Capital Expenditure | -8 | -5 | N/A | -8 | -7 |
| Free Cash Flow | -1,720 | -962 | -559 | -1,600 | -1,203 |